Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket



  • Aptevo Therapeutics Inc. APVO shares rose 104% to $7.00 in pre-market trading. Aptevo Therapeutics said 100% clinical benefit rate was achieved in Phase 1b trial evaluating Apvo436 in combination with venetoclax & azacitidine for venetoclax treatment naïve patients with acute myeloid leukemia, Reuters reported.
  • HTG Molecular Diagnostics, Inc. HTGM shares rose 38.9% to $0.7499 in pre-market trading after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
  • Bruush Oral Care Inc. BRSH shares rose 26% to $0.6110 in pre-market trading. Bruush Oral Care reported closing of $3.0 million private placement.
  • SeqLL Inc. SQL rose 24.2% to $0.5587 in pre-market trading after jumping 15% on Friday. SeqLL, last month, reported a Q3 loss of $0.08 per share.
  • Coupa Software Incorporated COUP rose 22.4% to $75.97 in pre-market trading. Private-equity firm Thoma Bravo is in advanced talks to buy Coupa Software and the transaction could be announced as early as this week, Bloomberg reported, citing people familiar with the matter. Coupa is also expected to release quarterly earnings after the closing bell today.
  • Faraday Future Intelligent Electric Inc. FFIE rose 20.2% to $0.3551 in pre-market trading after gaining over 11% on Friday. Faraday Future Intelligent Electric recently appointed FF China CEO Xuefeng (XF) Chen as Global CEO of the company, effective immediately.
  • Taoping Inc. TAOP rose 20% to $1.02 in pre-market trading. Taoping, last month, reported a 3-year strategic cooperation with ZhongShengShi and is expected to generate more than $14 million.
  • Aptose Biosciences Inc. APTO rose 18.3% to $0.8285 in pre-market trading. Aptose said Tuspetinib continues to deliver single agent responses in r/r AML patients at ASH 2022.
  • China Jo-Jo Drugstores, Inc. CJJD rose 17.5% to $3.89 in pre-market trading after jumping 53% on Friday.
  • China SXT Pharmaceuticals, Inc. SXTC rose 16.7% to $0.6772 in pre-market trading after gaining over 20% on Friday.
  • Reborn Coffee, Inc. REBN rose 16% to $1.23 in pre-market trading after jumping around 22% on Friday. Reborn Coffee recently signed a Letter of Intent to acquire a specialty coffee shop and a roasting research and development facility in Daejeon, South Korea as a part of its global expansion plan.
  • Insmed Incorporated INSM rose 15.1% to $21.24 in pre-market trading. Mizuho recently initiated coverage on Insmed with a Buy rating and announced a price target of $28.
  • Horizon Therapeutics Public Limited Company HZNP rose 14.1% to $111.00 in pre-market trading. Bloomberg reported that Amgen is set to buy Horizon Therapeutics for about $116.50 per share.
  • Harpoon Therapeutics, Inc. HARP rose 13.9% to $1.31 in pre-market trading. Harpoon Therapeutics presented updated interim results at ASH 2022 for Novel T cell engager HPN217 in Relapsed/Refractory Multiple Myeloma.
  • Turkcell Iletisim Hizmetleri A.S. TKC rose 8% to $4.59 in pre-market trading. Turkcell, last month, posted Q3 revenue of 14.20 billion Lira.
  • AMC Entertainment Holdings, Inc. APE rose 6.6% to $0.82 in pre-market trading after declining around 7% on Friday.

Don’t forget to check out our premarket coverage here .


  • Ambrx Biopharma Inc. AMAM fell 26% to $3.36 in pre-market trading. Ambrx Biopharma shares jumped over 1,007% on Friday after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
  • Baudax Bio, Inc BXRX shares fell 18.1% to $4.26 in pre-market trading. Baudax Bio shares gained around 28% on Friday after the company announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery.
  • IronNet, Inc. IRNT fell 17.4% to $0.25 in pre-market trading after gaining around 4% on Friday. The company recently partnered with AWS Marketplace to provide complimentary access to IronRadar Technology.
  • Advanced Human Imaging Limited AHI fell 16.9% to $0.4405 in pre-market trading after jumping 36% on Friday. Advanced Health Intelligence named Scott Montgomery as CEO.
  • INVO Bioscience, Inc. INVO shares fell 16.5% to $0.50 in pre-market trading after jumping over 30% on Friday. The company, last month, posted downbeat quarterly results.
  • Steakholder Foods Ltd. STKH shares fell 15.3% to $0.81 in pre-market trading after dipping over 11% on Friday.
  • Meta Materials Inc. MMAT fell 12.7% to $1.24 in pre-market trading after dipping 22% on Friday. Meta Materials recently announced FINRA has processed and announced the corporate action of exchanging META's Series A Preferred shares for shares of common stock of Next Bridge Hydrocarbons on its daily list.
  • Ensysce Biosciences, Inc. ENSC shares fell 11.3% to $1.06 in pre-market trading after jumping 21% on Friday. Ensysce Biosciences recently announced pricing of a $4.1 million public offering.
  • Hillstream BioPharma, Inc. HILS fell 10.3% to $0.5470 in pre-market trading after climbing 43% on Friday. Hillstream BioPharma recently company announced the development of proprietary targeted biologics, Knob Quatrabodies against PD-1.
  • Borqs Technologies, Inc. BRQS fell 9.3% to $0.2403 in pre-market trading. Borqs' subsidiary, Holu Hou Energy, recently received multiple orders for HoluPower xP Solar Energy Storage Systems in CA.
  • Panbela Therapeutics, Inc. PBLA fell 8.9% to $0.09 in pre-market trading.
  • Adicet Bio, Inc. ACET fell 5.9% to $16.25 in pre-market trading after the company reported data from ongoing ADI-001 Phase 1 Trial in patients with relapsed or refractory aggressive B-Cell Non-Hodgkin’s Lymphoma.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!